CAS: 1035875-01-4
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide REF: 3D-KRB87501CAS: 1035875-01-4 | Min. 95% | Nachfragen | Mo 13 Jan 25 |
 | RETRA REF: TM-T24709CAS: 1035875-01-4 | 98% | 904,00 €~2.329,00 € | Di 21 Jan 25 |
![2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide](https://static.cymitquimica.com/products/3D/thumb/KRB87501.jpg)
2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide
CAS:1035875-01-4
2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide is a potent inhibitor of protein interactions and activator of ligands. It is …
Formel:
C11H12BrNO3S2
Reinheit:
Min. 95%
Molekulargewicht:
350.3 g/mol
Ref: 3D-KRB87501
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 13. Januar 2025
RETRA
CAS:1035875-01-4
RETRA is an agent of anticancer that acts by exerting anticancer activity in Ewing's sarcoma …
Formel:
C11H12BrNO3S2
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
350.25
Ref: TM-T24709
| 25mg | 1.410,00 € | ||
| 50mg | 1.845,00 € | ||
| 100mg | 2.329,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 21. Januar 2025
